4Stedman CA,Barclay ML.Review article:comparison of the pharmacokinetics,acid suppression and efficacy of proton pump inhibitors[J].Aliment Pharmacol Ther,2000,14:963～978.
1Katz PO. Anderson C, Khoury R, et al. Gastro- oesophageal reflex associated with nocturnal gastrie acid breakthrough on proton punp inhibitors[J]. Aliment Pharmacol Ther 1998, 12:1231 - 1234.
2Williams MP, Sercombe J, Hamilton MI, et al. Aplacebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric and plasma gastrin concentrations in young healthy male subjects [J]. Aliment Pharmacol Ther 1998,12:1079-1089.
3Yasuda S, Horai Y, Tomono Y, et al. Comparison of the kinetic disposition and metabolism of E3810, a new proton punp inhibitor, and omeprazole in relation to S - mephenytoin 4i - hydroxylation staus [J]. Clinic Pharmacol Ther 1995, 9:363 -378.
4Sohn D-R,Kwon J-T, Kim H-K, et al. Metabolic disposition of lansoprazole in relation to the S- mephnytoin 4i-hydroxylation phenotype status[J]. Clinic Pharmacol Ther 1997,61:574 - 582.
5Tanaka M, Ohkubo T, Otani K, et al. Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S -mephenytoin 4' - hydroxylation phenotype and genotype[J].Clinic Pharmacol Ther 1997, 62:619-628.
6Stedman CA, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther, 2000,14:963-978.
7Sachs G, Shin JM, Briving C, et al. The pharmacology of the gastric acid pump: the H+,K+ ATPase. Annu Rev Pharmacol Toxicol,1995,35:277-305.
9Besancon M, Simon A, Sachs G, et al. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. J Biol Chem,1997,272:22438-22446.
10Stedman CA,Barclay ML.Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors[].Alimentary Pharmacology and Therapeutics.2000
